Avidity Partners Management LP Horizon Therapeutics Public LTD CO Transaction History

Avidity Partners Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $22.1 Million - $31.7 Million	-374,700 Reduced 20.18%	1,482,200 $91.7 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $57.6 Million - $84.4 Million	725,500 Added 64.12%	1,856,900 $148 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $10.3 Million - $13.1 Million	119,400 Added 11.8%	1,131,400 $119 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $18.3 Million - $22.3 Million	186,000 Added 22.52%	1,012,000 $109 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $23.7 Million - $28.5 Million	258,000 Added 45.42%	826,000 $90.5 Million

Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $1.12 Million - $1.25 Million	-13,000 Reduced 2.24%	568,000 $53.2 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $42.3 Million - $56.2 Million	-588,300 Reduced 50.31%	581,000 $53.5 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $16 Million - $20.2 Million	239,100 Added 25.7%	1,169,300 $85.5 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $21.8 Million - $31.5 Million	394,000 Added 73.48%	930,200 $72.3 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $6.14 Million - $11.6 Million	203,200 Added 61.02%	536,200 $29.8 Million
Q1 2020 Jun 17, 2020	BUY	$24.87 - $38.56 $8.28 Million - $12.8 Million	333,000 New	333,000 $9.86 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $3.73 Million - $5.78 Million	-150,000 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$25.43 - $36.67 $3.81 Million - $5.5 Million	150,000 New	150,000 $5.43 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.